|
03/09/2010 11:34 PM
|
|
Sanofi joins Merck in animal health venture
|
The pharmaceutical group has agreed a deal to establish a joint venture with Merck which will be the world's largest animal health business
|
|
03/09/2010 04:56 PM
|
|
Bupa's Asia growth mitigates UK, US slowness
|
Strong growth in customer numbers in Asia and the acquisition of MBF, the Australian insurer, helps mitigate sluggish performance of the medical insurance group in the US and UK
|
|
03/08/2010 10:10 PM
|
|
Regulator finds ethics breach by AstraZeneca
|
A UK regulatory panel says the pharmaceutical group failed to accurately reflect the side effects of its top-selling antipsychotic drug Seroquel in an advertisement to doctors
|
|
03/08/2010 06:57 PM
|
|
AstraZeneca job cuts reflect new landscape
|
Anglo-Swedish pharmaceuticals group's move is latest in series of shake-ups that will have a key impact on the volume of medical innovation
|
|
03/08/2010 01:18 AM
|
|
Scottish start-up in £70m Sinopharm deal
|
Under the partnership agreement, the Chinese pharmaceutical distributor will undertake the regulatory compliance process in Beijing for Burdica Biomed's range of personal lubricants
|
|
03/05/2010 11:12 PM
|
|
3i buys majority stake in health chain
|
The UK's oldest private equity firm feels it has recovered sufficiently from the financial crisis to return to the dealmaking fray
|
|
03/04/2010 02:15 AM
|
|
Care UK goes private via Bridgepoint
|
The all-cash offer of 450p a share from private equity group Bridgepoint represents a premium and values the provider of nursing and elderly home care at £423m
|
|
03/03/2010 11:01 PM
|
|
Inquiry into NHS provider rule halted
|
Primary care health trusts across the east of England have been ordered to suspend procurement for community services
|
|
03/03/2010 04:27 PM
|
|
UK receives venture capital boost
|
The sector gets a double lift from the $330m sale of a biotechnology company to a US pharmaceutical group and a £65m fundraising round by a developer of painkillers for cancer patients
|
|
03/03/2010 02:53 AM
|
|
Four Seasons faces new creditor talks
|
One of the UK's largest care group is set to be dragged back into talks after a group of bondholders threatened to block an attempt to renegotiate the terms of its debts
|
|
03/03/2010 01:26 AM
|
|
Ratiopharm sale in final stages
|
Teva Pharmaceutical Industries of Israel, Actavis of Iceland and Pfizer of the US are said to be vying to win control of the German generic drug company in the €3bn auction
|
|
03/03/2010 12:10 AM
|
|
Barclays Private Equity to sell Deb Group
|
Buy-out company is to announce the sale of the cleaning products maker to Charterhouse in a deal worth £325m
|
|
03/02/2010 10:48 PM
|
|
AstraZeneca to halt leading disease research
|
Anglo-Swedish group to cease research into several diseases that have generated its largest selling drugs
|
|
03/02/2010 10:44 PM
|
|
Astellas raises OSI bid pressure
|
The Japanese pharmaceutical company intensified the pressure of its hostile $3.5bn bid for OSI with a legal action designed to prevent its US target from issuing a poison pill
|
|
03/02/2010 09:24 PM
|
|
HgCapital says Goldshield understated profits
|
Private equity group appoints lawyers and accountants to investigate whether drugmaker it bought understated profits while a listed comany
|
